Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Verastem, Inc. (VSTM)  
$12.02 0.17 (1.43%) as of 4:30 Mon 5/13


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 25,230,000
Market Cap: 303.26(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.8 - $14.07
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Verastem is a late stage development biopharmaceutical company, with ongoing registration directed trials, focused on developing and commercializing medicines for patients battling cancer. Co.'s product candidates, VS-6766 and defactinib, are being investigated in both preclinical and clinical studies for the treatment of various solid tumors. VS-6766 is an orally available small molecule rapidly accelerated fibrosarcoma/ mitogen-activated protein kinase kinase clamp. Defactinib is an oral small molecule inhibitor of Focal Adhesion Kinase and proline-rich tyrosine kinase that is being evaluated as a potential combination therapy for various solid tumors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 1,735 21,833 25,311 165,018
Total Sell Value $18,442 $258,319 $292,764 $385,800
Total People Sold 4 4 4 4
Total Sell Transactions 9 20 37 63
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 268
  Page 10 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-04-17 4 AB $9.53 $7,624 D/D 800 702,089     -
   Chp Iii Lp 10% Owner   –       –       •   2013-04-17 4 B $9.50 $53,489 D/D 5,631 2,245,950 2.45     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-04-09 4 A $8.98 $9,068 D/D 1,000 701,289     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-04-02 4 D $9.44 $55,148 D/D (5,842) 700,289     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-04-01 4 A $9.55 $7,685 D/D 800 706,131     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-03-21 4 AB $9.04 $7,232 D/D 800 705,331     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-03-13 4 A $9.32 $7,467 D/D 800 704,531     -
   Forrester Robert President and COO   •       –      –    2013-03-12 4 D $9.37 $158,194 D/D (16,883) 253,974     -
   Pachter Jonathan VP, Head of Research   •       –      –    2013-03-12 4 D $9.37 $94,393 D/D (10,074) 75,640     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-03-12 4 D $9.37 $345,416 D/D (36,864) 703,731     -
   Paterson Dan Head of Corp. Dev.,Diagnostics   •       –      –    2013-03-12 4 D $9.37 $125,811 D/D (13,427) 100,859     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-03-05 4 AB $9.47 $7,576 D/D 800 740,595     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-02-25 4 A $9.93 $7,972 D/D 800 739,795     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-02-06 4 A $9.65 $7,919 D/D 800 738,995     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-01-29 4 AB $10.00 $3,000 D/D 300 712,369     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2013-01-18 4 A $9.97 $7,995 D/D 800 712,069     -
   Westphal Christoph H President and C.E.O.   •       •       •   2013-01-02 4 AB $9.73 $7,784 D/D 800 711,269     -
   Westphal Christoph H Chief Executive Officer   •       •       •   2012-12-28 4 A $0.00 $0 D/D 25,826 738,195     -
   Westphal Christoph H President and C.E.O.   •       •       •   2012-12-21 4 A $8.72 $8,854 D/D 1,000 710,469     -
   Clarke John K Director   –       •      –    2012-12-18 4 AB $7.87 $48,739 I/I 6,193 2,240,319     -
   Paterson Dan Head of Corp. Dev.,Diagnostics   •       –      –    2012-12-04 3 IO $0.00 $0 D/D 0 114,286     -
   Westphal Christoph H President & Chief Exec Officer   •       •       •   2012-09-18 4 A $0.00 $0 D/D 206,612 709,469     -
   Clarke John K Director   –       •      –    2012-02-01 4 B $10.00 $2,500,000 I/I 250,000 2,234,126 2.1     -
   Clarke John K Director   –       •      –    2012-02-01 4 A $0.00 $0 I/I 1,984,126 1,984,126     -
   Gadicke Ansbert Director   –       •      –    2012-02-01 4 B $10.00 $1,000,000 I/I 100,000 3,740 2.1     -
  268 Records found
  Previous  10  11   
  Page 10 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us